6 FIN Sponsors

Actelion

Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs.

Actelion

Amicus Therapeutics

Amicus Therapeutics is pioneering a paradigm-shifting approach to treating a range of human genetic diseases in which crucial proteins are misfolded, thus reducing or eliminating their functionality. Amicus develops pharmacological chaperones - oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. This novel, next-generation approach offers the potential to improve treatment options for patients with genetic diseases.

Amicus

Genzyme

Genzyme is one of the world’s leading biotechnology companies. Its more than 10,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases

Genzyme

Interaction Institute for Social Change

IISC is a non-profit organisation that
partners with individuals, organizations
and communities to achieve greater
social impact. It does this through providing training, facilitation and coaching services to the public and not-for-profit sectors.

Sanders & Clients BV

Sanders & Clients BV
is a Dutch company that deliver equipment to infuse the medicine.

Shire

Shire is a global company with offices in the major pharmaceutical markets. Its world headquarters are in Basingstoke, UK and its US headquarters in Wayne, Pennsylvania.

Shire
Sponsored by:
untitled untitled untitled